MA
ELV icon

Maxele Advisors’s Elevance Health ELV Stock Holding History

Maxele Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-535
Closed -$208K – 97
2025
Q2 		$208K Hold
535
– – 0.18% 100
2025
Q1 		$233K Sell
535
-45
-8% -$18.1K 0.22% 92
2024
Q4 		$214K Buy
+580
New +$243K 0.2% 93
2022
Q3 		$308K Sell
679
-15
-2% -$7.18K 0.52% 53
2022
Q2 		$335K Sell
694
-14
-2% -$6.93K 0.53% 53
2022
Q1 		$348K Sell
708
-62
-8% -$28.3K 0.43% 59
2021
Q4 		$357K Buy
+770
New +$324K 0.41% 64

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $74.9B AUM 11.27% 1-Year Est. Return